Načítá se...
Apolipoprotein Measurements: Is More Widespread Use Clinically Indicated?
Apolipoprotein (apo) B may be a more sensitive measure of atherogenicity than low‐density lipoprotein cholesterol (LDL‐C) and a better index for assessing cardiovascular risk. The refined risk assessment provided by apo B may be important in patients at high cardiometabolic risk such as those with d...
Uloženo v:
| Vydáno v: | Clin Cardiol |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Wiley Periodicals, Inc.
2009
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6653425/ https://ncbi.nlm.nih.gov/pubmed/19743499 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.20559 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|